NUTX Nutex Health Inc.: institutional ownership and insider trading
160 funds reported holding $550M of Nutex Health Inc. in their latest 13F filings; in Q2 2026 funds net bought $21.9M, with 35 new positions and 12 funds selling out; over the last 12 months insiders bought $148K and sold $43.5K on the open market; over its last four quarters it reported revenue of $847M and net income of $180M.
NUTX revenue and earnings
- Quarter ended Jun 30, 2026: revenue $211M, net income $65.8M, EPS 9.38
- Quarter ended Mar 31, 2026: revenue $216M, net income $46.8M, EPS 6.52
- Quarter ended Dec 31, 2025: revenue $152M, net income $11.8M, EPS 2.34
- Quarter ended Sep 30, 2025: revenue $268M, net income $55.4M, EPS 7.76
Famous investors holding NUTX
- D. E. Shaw (D. E. Shaw & Co.): $16.7M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $8.90M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $3.13M, 0.0% of the portfolio
Largest institutional holders of NUTX
- Pertento Partners LLP — $77.1M
- BlackRock, Inc. (BLK) — $69.6M
- VANGUARD GROUP INC — $42.6M
- AMERICAN CENTURY COMPANIES INC — $40.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $36.9M
- GEODE CAPITAL MANAGEMENT, LLC — $22.6M
- STATE STREET CORP (STT, STT-PG) — $22.4M
- D. E. Shaw & Co., Inc. — $16.7M
- UBS Group AG (UBS) — $13.3M
- WINMILL & CO. INC — $11.2M
Recent NUTX insider trades
- Sep 18, 2026: Saunders Scott J sold 203 shares ($43.5K)
- Mar 20, 2026: Jaumot Frank E bought 150 shares ($14.0K)
- Mar 19, 2026: Hosseinion Warren bought 252 shares ($23.7K)
- Mar 17, 2026: Spears Kelvin bought 10 shares ($945)
5%+ owners
- Pertento Partners LLP: 5.9% (Schedule 13G/A, filed May 7, 2026)
- BlackRock, Inc.: 5.3% (Schedule 13G, filed Apr 27, 2026)